Form 4: Zimmer Biomet Director Arthur J. Higgins Reports Acquisition of Phantom Stock Units

Director Arthur J. Higgins reports acquiring phantom stock units in Zimmer Biomet Holdings, Inc. through a deferred compensation plan.

Summary

• Arthur J. Higgins, a director of Zimmer Biomet Holdings, Inc., reported the acquisition of phantom stock units on September 30, 2024.
• The acquisition was made under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.
• A total of 255.197 phantom stock units were acquired at a price of $107.76 per unit.
• Following the transaction, Higgins beneficially owns 33,362.603 phantom stock units.
• These units will be settled in cash in ten annual installments after Higgins ceases to be a director.
• The report also includes 70.502 phantom stock units accrued on July 31, 2024, under the dividend reinvestment provision of the deferred compensation plan.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive. It reflects a routine transaction related to director compensation, indicating alignment of interests with shareholders through equity ownership. There are no explicit negative implications.

Positives

• The acquisition of phantom stock units aligns the director's interests with the long-term performance of the company.
• The deferred compensation plan provides a mechanism for directors to accumulate wealth tied to the company's success.

Future Outlook

The phantom stock units will be settled in cash in ten annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs.

Industry Context

This filing is a routine disclosure related to executive compensation and is common among publicly traded companies. It reflects the standard practice of using equity-based compensation to align the interests of directors with those of shareholders.

Comparison to Industry Standards

• Deferred compensation plans are a common practice among large, publicly traded companies like Zimmer Biomet to attract and retain qualified board members.
• Companies such as Johnson & Johnson and Medtronic also utilize similar compensation structures for their non-employee directors.
• The specific terms of the plan, such as the vesting schedule and payout method, are generally in line with industry norms.

Stakeholder Impact

• The acquisition of phantom stock units by a director can positively influence shareholder confidence by aligning the director's interests with the company's long-term success.
• Employees may view this as a positive sign of leadership commitment to the company's future.

Key Dates